Weaver Consulting Group X Biotech Inc. Transaction History
Weaver Consulting Group
- $293 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding XBIT
# of Institutions
50Shares Held
4.87MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$4.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$4.52 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$1.93 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$1.2 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$1.08 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $130M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...